قالب وردپرس درنا توس
Home / Business / The debate about who started using the COVID-19 vaccine for the first time begins

The debate about who started using the COVID-19 vaccine for the first time begins



Who will be the first to receive the COVID-19 vaccine? The US health authorities hope to develop some draft guidance on how to dispense the initial dose by the end of next month, but this is an annoying decision.

Dr. Francis Collins, director of the National Institutes of Health, said: “Not everyone will like this answer.” The government told an advisory group and asked the government to help make a decision. “There will be many people who think they should be at the top of the list.”

Traditionally, it is health workers and those most vulnerable to targeted infections that need rare vaccines first.

But Collins came up with a new idea: Considering geographical factors, put the people with the worst outbreaks first.

Also, don’t forget the volunteers who got fake injections in the final stage of the vaccine test. The comparison team needs to tell you whether the real injections are really effective.

“We owe them… some special priorities,”

; Collins said.

Lots of research this summer The purpose is to prove which of several experimental COVID-19 vaccines are safe and effective. Moderna Inc. and Pfizer Inc. started testing last week and will eventually include 30,000 volunteers each. In the next few months, the same large number of volunteers called for the testing of lenses from AstraZeneca, Johnson & Johnson and Novavax. Some vaccines produced in China have been studied in other countries with smaller late-stage studies.

For all the promises of millions of doses of vaccines in the United States, there is one last word: even if a vaccine is declared safe and effective by the end of the year, there is not enough power for everyone who wants to use it right away-especially most potential vaccines Both require two doses.

This is a global problem. The World Health Organization is working to solve the same “ask first” question as it seeks to ensure that the vaccine is fairly distributed to poor countries-as rich countries bring the first dose to the market, decision-making becomes more difficult.

In the United States, the immunization practice advisory committee established by the Centers for Disease Control and Prevention should recommend who should be vaccinated, and when to recommend the government almost always follow.

However, the COVID-19 vaccine decision is so difficult that this time Congress also asked ethicists and vaccine experts from the National Academy of Medicine to provide advice to the government.

Bill Fogg, who developed a vaccination strategy that led to the global eradication of smallpox, said that setting priorities will require “creative, ethical common sense.” Foege co-led the college’s deliberations, calling it “both opportunities and burdens.”

CDC Director Robert Redfield said that due to the proliferation of vaccine misinformation and fear that politics may intervene, the public must regard vaccine distribution as “fair, just and transparent.”

How to decide? The opening recommendation of the CDC: First vaccinate 12 million most critical health, national security and other essential workers. Next will be 110 million people at high risk of coronavirus-people over 65 who live in long-term care facilities, people of any age with poor health-or workers who are also considered essential. The general population will be late.

The CDC vaccine consultant wants to know who really matters. Dr. Peter Szilagyi, a pediatrician at the University of California, Los Angeles, admitted: “I would not consider myself a key health care worker.”

Indeed, the risks faced by health workers today are very different from those at the beginning of the pandemic. Now, medical staff in COVID-19 treatment units are usually the best protected. Committee members pointed out that other risks may be greater.

In addition to the health and safety field, “essential” refers to the staff of the poultry farm or school teachers? What if the vaccine does not work well among vulnerable people and young, healthy people? Given that the immune system of the elderly cannot adapt well to the flu vaccine, this is indeed worrying.

ACIP Chairman, Arkansas Interim Secretary of Health, Dr. Jose Romero, said that because blacks, Latinos and Native Americans are disproportionately hit by the coronavirus, failure to resolve the diversity issue means “anything in our group will be suspicious. attention.”

Dr. Sharon Frey of St. Louis University added that considering the urban poor living in a crowded environment, without access to health care, and unable to work from home like more privileged Americans.

Dr. Henry Bernstein of Northwell Health said it might be worth vaccinating the entire family instead of just picking out the high-risk groups in one family.

No matter who goes first, mass vaccination while people should keep their distance is a daunting task. During the swine flu pandemic in 2009, when it was their turn, families lined up in the parking lot and the health department, the crowd was crowded, and the authorities knew they had to avoid this time.

The Trump administration’s efforts to speed up the production and distribution of vaccines, known as Warp Speed, are studying how to quickly deliver the correct amount of doses to any place where the vaccine will be vaccinated.

CDC’s Dr. Nancy Messonnier said that tax-free vaccinations, pop-up clinics and other innovative ideas are all on the table.

Messonnier said that once a vaccine is declared effective, “Frankly, we hope to start these plans the next day.” “This is a long way.”

___

The Associated Press Department of Health and Science is supported by the Howard Hughes Medical Institute’s Department of Science Education. AP is solely responsible for all content.


Source link